Features CRO Industry Report R&D trends, challenges in today’s market, and growth drivers and opportunities. June 19, 2024 ...

Pharma Matters Q&A Breathing New Life into Grimsby: IPP’s Vision for Sustainable Industrial Redevelopment How repurposing the former Novartis plant aligns with IPP’s commitment to the circular economy ...

A quick reference of all the mergers and acquisitions taking place within the global pharmaceuticals market.

In today’s evolving pharmaceutical environment, the fill‐finish segment stands out as a critical linchpin connecting drug development with successful patient delivery. Driven by seismic shifts in ...

Biosimilar uptake in the US market has, until now, stood in stark contrast to that in the EU, which has led the way in biosimilar approvals and use since 2006. There are many signs, however, that the ...

Clarivate identifies eleven drugs it believes are poised to reach blockbuster status by 2030 or dramatically improve patient outcomes on a global scale.

Continuity Biosciences, LLC, a new bioscience company dedicated to developing and commercializing cutting-edge technologies for cell reprogramming, immune modulation, and drug delivery, has officially ...

Jabil Inc., a provider of engineering, manufacturing, and supply chain solutions, has acquired Pharmaceutics International Inc. (Pii), a contract development and manufacturing organization (CDMO) ...

Invests in R&D activities at Vertolaye site to increase production of morphine that could increase productivity between 20% and 30%.

Features Preparing For Your CDMO Selection Process Five questions that must be answered before starting your CDMO search.

Regeneron Pharmaceuticals Inc. has announced the formation of Regeneron Cell Medicines based on an agreement with 2seventy bio, Inc. to acquire full development and commercialization rights to its ...

The contract development and manufacturing organization (CDMO) sector is having to quickly respond to challenges within the pharmaceutical industry, particularly as drug substances become increasingly ...